We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FGL:NASDAQFounder Group Limited Analysis

Data as of 2026-04-02 - not real-time

$2.46

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Founder Group Limited is trading near its technical support level while the short‑term moving averages sit well above the market price, signalling a bearish price context. Momentum indicators show the RSI in oversold territory and the MACD histogram turning slightly positive, hinting at a potential short‑term bounce. However, the company’s fundamentals are distressed: earnings per share are deeply negative, cash flow is negative, and leverage is towering, with debt far exceeding equity. The price‑to‑book ratio is a fraction of one and price‑to‑sales is minuscule, suggesting the market has priced in severe risk. Recent contract wins in the solar EPC space provide a modest catalyst, but the firm also faces compliance and potential delisting concerns, adding regulatory headwinds. Volatility is extreme and beta exceeds the market, amplifying price swings.
Given the mix of technical oversold signals, ultra‑low valuation multiples, and a precarious financial and regulatory backdrop, the stock appears highly speculative. Investors should weigh the upside from new project contracts against the substantial debt burden, negative cash generation, and the risk of further listing actions before forming a position.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Oversold RSI and slight MACD bullish hint
  • Price near technical support
  • Negative earnings and cash flow

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • New solar EPC contracts adding revenue pipeline
  • Ultra‑low valuation multiples
  • Potential compliance recovery

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • High leverage and ongoing cash‑flow deficits
  • Exposure to regulatory and delisting risk
  • Sustained volatility and weak profitability

Key Metrics & Analysis

Financial Health

Revenue Growth82.20%
Profit Margin-4.65%
ROE-35.33%
ROA-3.04%
Debt/Equity367.36
P/B Ratio0.1
Op. Cash Flow$-25714686
Free Cash Flow$-6631617
Industry P/E28.9

Technical Analysis

TrendBearish
RSI29.1
Support$2.05
Resistance$7.92
MA 20$4.35
MA 50$9.22
MA 200$52.74
MACDBullish
VolumeStable
Fear & Greed Index78.8

Valuation

GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.24
Volatility178.80%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.